首页/数据集/Metronomic doxorubicin blocks HIF-1α-mediated responses in sarcomas and augments the effects of anti-VEGF-A therapy

Metronomic doxorubicin blocks HIF-1α-mediated responses in sarcomas and augments the effects of anti-VEGF-A therapy

ChEBI2011-08-29 更新2026-07-21 收录

肉瘤靶向治疗

抗血管生成药物联合疗法

数据链接：

https://www.ebi.ac.uk/biostudies/ArrayExpress/studies/E-GEOD-31715 数据链接链接失效反馈

官方服务：

资源简介：

Metronomic doxorubicin blocks HIF-1α-mediated responses in sarcomas and augments the effects of anti-VEGF-A therapy

应用场景：

创建时间：

2011-08-29

结直肠癌精准治疗

抗血管生成药物联合疗法

The purpose of this study is to determine whether Endostar pumping into vein with Thalidomide are more effective in the treatment of Advanced Colorectal Cancer (ACRC).

NIAID Data Ecosystem110

Targeting KDM4 for treating PAX3-FOXO1-driven alveolar rhabdomyosarcoma [CUT&RUN, 2]. Targeting KDM4 for treating PAX3-FOXO1-driven alveolar rhabdomyosarcoma [CUT&RUN, 2]

肉瘤靶向治疗

表观遗传药物靶点

Chimeric transcription factors drive lineage-specific oncogenesis but are notoriously difficult to target. Alveolar rhabdomyosarcoma (RMS) is an aggressive childhood soft tissue sarcoma transformed by

NIAID Data Ecosystem80

DataSheet_1_The Efficacy and Safety of Anlotinib Combined With PD-1 Antibody for Third-Line or Further-Line Treatment of Patients With Advanced Non-Small-Cell Lung Cancer.doc

非小细胞肺癌后线治疗

抗血管生成药物联合疗法

BackgroundBoth anlotinib and programmed death 1 (PD-1) monoclonal antibody (mAb) have been approved for the third line treatment of metastatic non-small cell lung cancer (NSCLC). However, the combinat

NIAID Data Ecosystem60

Therapeutic Targeting Ewing Sarcoma through Inhibition of the FACT Complex (ChIP-Seq)

肉瘤靶向治疗

FACT复合物

EWS/ETS fusion transcription factors, most commonly EWSR1-FLI1, drive initiation and progression of Ewing sarcoma (EwS), a highly aggressive childhood cancer of bone and soft tissues. Even though dire

NIAID Data Ecosystem100

Therapeutic Targeting Ewing Sarcoma through Inhibition of the FACT Complex (RNA-Seq II). Therapeutic Targeting Ewing Sarcoma through Inhibition of the FACT Complex (RNA-Seq II)

肉瘤靶向治疗

转录组学药物筛选

NIAID Data Ecosystem60